These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. [Treatment of hairy cell leukemia with cladribine]. Aurer I; Mitrović Z; Kovacević-Metelko J; Radman I; Basić-Kinda S; Gjadrov-Kuvezdić K; Jakić-Razumović J; Dubravcić K; Ries S; Nola M; Zupancic-Salek S; Labar B Lijec Vjesn; 2007; 129(3-4):80-3. PubMed ID: 17557550 [TBL] [Abstract][Full Text] [Related]
4. Imatinib mesylate therapy improves survival in patients with newly diagnosed Philadelphia chromosome-positive chronic myelogenous leukemia in the chronic phase: comparison with historic data. Kantarjian HM; O'Brien S; Cortes J; Giles FJ; Rios MB; Shan J; Faderl S; Garcia-Manero G; Ferrajoli A; Verstovsek S; Wierda W; Keating M; Talpaz M Cancer; 2003 Dec; 98(12):2636-42. PubMed ID: 14669283 [TBL] [Abstract][Full Text] [Related]
5. Comparison between patients with Philadelphia-positive chronic phase chronic myeloid leukemia who obtained a complete cytogenetic response within 1 year of imatinib therapy and those who achieved such a response after 12 months of treatment. Iacobucci I; Rosti G; Amabile M; Poerio A; Soverini S; Cilloni D; Testoni N; Abruzzese E; Montefusco E; Ottaviani E; Iuliano F; Russo D; Gobbi M; Alimena G; Martino B; Terragna C; Pane F; Saglio G; Baccarani M; Martinelli G J Clin Oncol; 2006 Jan; 24(3):454-9. PubMed ID: 16421422 [TBL] [Abstract][Full Text] [Related]
7. Effects of age on prognosis with imatinib mesylate therapy for patients with Philadelphia chromosome-positive chronic myelogenous leukemia. Cortes J; Talpaz M; O'Brien S; Giles F; Beth Rios M; Shan J; Faderl S; Garcia-Manero G; Ferrajoli A; Wierda W; Kantarjian H Cancer; 2003 Sep; 98(6):1105-13. PubMed ID: 12973833 [TBL] [Abstract][Full Text] [Related]
8. Imatinib mesylate in Philadelphia chromosome-positive leukemia of childhood. Kolb EA; Pan Q; Ladanyi M; Steinherz PG Cancer; 2003 Dec; 98(12):2643-50. PubMed ID: 14669284 [TBL] [Abstract][Full Text] [Related]
9. [Imatinib--en epoch-making new drug against chronic myeloid leukemia]. Lakartidningen; 2003 Jun; 100(26-27):2283. PubMed ID: 12872372 [No Abstract] [Full Text] [Related]
10. Development of acute myeloid leukemia associated with Ph-negative clone with inv(3)(q21q26) during imatinib therapy for chronic myeloid leukemia. Dvorak P; Hruba M; Subrt I Leuk Res; 2009 Jun; 33(6):860-1. PubMed ID: 18977531 [No Abstract] [Full Text] [Related]
11. New leukemia drug shows promise against Gleevec resistance. Ashraf H Drug Discov Today; 2005 Apr; 10(7):453-4. PubMed ID: 15809187 [No Abstract] [Full Text] [Related]
12. Is imatinib a cost-effective treatment for newly diagnosed chronic myeloid leukemia patients? Goldman J Nat Clin Pract Oncol; 2005 Mar; 2(3):126-7. PubMed ID: 16264901 [No Abstract] [Full Text] [Related]
13. [Recent advances on molecular targets for treatment of acute leukemia]. Okuda T Nihon Rinsho; 2007 Jan; 65 Suppl 1():128-35. PubMed ID: 17474403 [No Abstract] [Full Text] [Related]